Get the Stockscreener App
3.87
1.31%
0.05
Clene Inc stock is traded at $3.87, with a volume of 62,658.
It is up +1.31% in the last 24 hours and down -9.58% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$3.82
Open:
$3.85
24h Volume:
62,658
Relative Volume:
0.71
Market Cap:
$31.99M
Revenue:
$442.00K
Net Income/Loss:
$-30.46M
P/E Ratio:
-0.8677
EPS:
-4.46
Net Cash Flow:
$-27.47M
1W Performance:
+3.75%
1M Performance:
-9.58%
6M Performance:
-19.37%
1Y Performance:
-10.62%
1-Day Range:
$3.7969
$3.9899
1-Week Range:
$3.63
$3.9899
52-Week Range:
$2.2801
$6.96
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
3.87 | 33.51M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
27.48 | 32.90B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
13.05 | 28.90B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
K
Kellanova
|
79.77 | 27.64B | 12.63B | 1.38B | 863.00M | 3.96 |
|
GIS
General Mills Inc
|
49.18 | 27.65B | 19.64B | 2.56B | 2.48B | 4.55 |
|
MKC
Mccormick Co Inc
|
70.74 | 19.31B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
What drives Clene Inc. Equity Warrant stock priceTremendous portfolio expansion - Autocar Professional
What analysts say about Clene Inc. stockFastest return on investment - Autocar Professional
Is Clene Inc. a good long term investmentFree Investment Community - Autocar Professional
Clene’s (CLNN) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Is Clene Inc. Equity Warrant a good long term investmentOutstanding risk-reward balance - Autocar Professional
What analysts say about Clene Inc. Equity Warrant stockUnprecedented profit potential - Autocar Professional
Clene Inc. Stock Analysis and ForecastDynamic capital growth - jammulinksnews.com
Clene Inc. Equity Warrant Stock Analysis and ForecastFree Consultation - jammulinksnews.com
What drives Clene Inc. stock priceUnprecedented growth rates - jammulinksnews.com
What makes Clene Inc. stock attractive to long term investorsFree Access to Community - beatles.ru
Promising Nanotechnology Stocks To Watch Now – July 16th - Defense World
Promising Nanotechnology Stocks To Watch NowJuly 16th - MarketBeat
How Clene Inc. stock performs during market volatilityHigh Potential Shares - Newser
Why Clene Inc. stock attracts strong analyst attentionParabolic Move Ideas - Newser
How Clene Inc. Equity Warrant stock performs during market volatilityBalanced Risk Reward Portfolio - Newser
What makes Clene Inc. Equity Warrant stock price move sharplyFree Stock Market Practical Discussion Forums - Newser
What makes Clene Inc. stock price move sharply200 Percent Watchlist - Newser
Why Clene Inc. Equity Warrant stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser
Best Nanotechnology Stocks Worth Watching – July 12th - Defense World
Promising Nanotechnology Stocks To Add to Your Watchlist – July 9th - Defense World
Promising Nanotechnology Stocks To Add to Your WatchlistJuly 9th - MarketBeat
Nanotechnology Stocks To Watch Today – July 7th - Defense World
Clene (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025 - Barchart.com
Clene Inc. (NASDAQ:CLNN) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Top Nanotechnology Stocks To Follow Today – July 5th - Defense World
Top Nanotechnology Stocks To Keep An Eye On – July 4th - Defense World
Nanotechnology Stocks To Research – July 3rd - Defense World
Clene working with FDA on accelerated approval for CNM-Au8 - ALS News Today
Clene files prospectus supplement for $2 million stock offering under existing agreement - Investing.com UK
Clene stock advances as FDA meetings approach for ALS treatment By Investing.com - Investing.com Nigeria
Clene stock maintains Buy rating at H.C. Wainwright on ALS drug progress - Investing.com India
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):